Diabetes and risk of esophageal and gastric adenocarcinomas

International Journal of Cancer

Volumn 131, Issue 6, 2012, Pages 1417-1422

  Jiang, Xuejuan ^a   Bernstein, Leslie ^b   Tseng, Chiu Chen ^a   Wu, Anna H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

case control study; diabetes; esophageal adenocarcinoma; gastric adenocarcinoma; polychotomous logistic regression

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN AMERICAN; BIRTHPLACE; BODY MASS; CANCER RISK; CARDIA CARCINOMA; CAUCASIAN; CIGARETTE SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CARDIA; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK; STOMACH NEOPLASMS;

EID: 84864143527     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27390     Document Type: Article

References (43)

1. International Diabetes Federation. IDF diabetes atlas, 4th edn. Brussels, Belgium: International Diabetes Federation, 2009.
2. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
3. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D,. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-85.
4. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I,. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307-14.
5. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S,. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871-7.
6. Kuriki K, Hirose K, Tajima K,. Diabetes and cancer risk for all and specific sites among Japanese men and women. Eur J Cancer Prev 2007; 16: 83-9.
7. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P,. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70: 950-3.
8. Rousseau MC, Parent ME, Pollak MN, Siemiatycki J,. Diabetes mellitus and cancer risk in a population-based case-control study among men from Montreal, Canada. Int J Cancer 2006; 118: 2105-9.
9. Stocks T, Rapp K, Bjorge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Johansen D, Concin H, Tretli S, Hallmans G, Jonsson H, et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 2009; 6: 1-14.
10. Chodick G, Heymann AD, Rosenmann L, Green MS, Flash S, Porath A, Kokia E, Shalev V,. Diabetes and risk of incident cancer: a large population-based cohort study in Israel. Cancer Causes Control 2010; 21: 879-87.
11. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM,. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.
12. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH,. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997; 89: 1360-5.
13. Khan M, Mori M, Fujino Y, Shibata A, Sakauchi F, Washio M, Tamakoshi A,. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 2006; 7: 253-9.
14. Ragozzino M, Melton LJ, III, Chu CP, Palumbo PJ,. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982; 35: 13-19.
15. Ikeda F, Doi Y, Yonemoto K, Ninomiya T, Kubo M, Shikata K, Hata J, Tanizaki Y, Matsumoto T, Iida M, Kiyohara Y,. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 2009; 136: 1234-41.
16. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK,. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006; 49: 945-52.
17. Cheng KK, Sharp L, McKinney PA, Logan RF, Chilvers CE, Cook-Mozaffari P, Ahmed A, Day NE,. A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 2000; 83: 127-32.
18. Neale RE, Doecke JD, Pandeya N, Sadeghi S, Green AC, Webb PM, Whiteman DC,. Does type 2 diabetes influence the risk of oesophageal adenocarcinoma? Br J Cancer 2009; 100: 795-8.
19. Rubenstein JH, Davis J, Marrero JA, Inadomi JM,. Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia. Aliment Pharmacol Ther 2005; 22: 267-71.
20. Reavis KM, Morris CD, Gopal DV, Hunter JG, Jobe BA,. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Ann Surg 2004; 239: 849- 56; discussion 56-8.
21. O'Mara BA, Byers T, Schoenfeld E,. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 1985; 38: 435-41.
22. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA,. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer 2011; 128: 635-43.
23. Lin S-W, Freedman ND, Hollenbeck A, et al. Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers. Cancer Epidemiol Biomarkers Prev 2011; 20: 954-61
24. Wu AH, Wan P, Bernstein L,. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States). Cancer Causes Control 2001; 12: 721-32.
25. Wu AH, Tseng CC, Bernstein L,. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 2003; 98: 940-8.
26. Wu AH, Tseng CC, Hankin J, Bernstein L,. Fiber intake and risk of adenocarcinomas of the esophagus and stomach. Cancer Causes Control 2007; 18: 713-22.
27. Wu AH, Crabtree JE, Bernstein L, Hawtin P, Cockburn M, Tseng CC, Forman D,. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003; 103: 815-21.
28. Cockburn MG, Wu AH, Bernstein L,. Etiologic clues from the similarity of histology-specific trends in esophageal and lung cancers. Cancer Causes Control 2005; 16: 1065-74.
29. Vigen C, Bernstein L, Wu AH,. Occupational physical activity and risk of adenocarcinomas of the esophagus and stomach. Int J Cancer 2006; 118: 1004-9.
30. Duan L, Wu AH, Sullivan-Halley J, Bernstein L,. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiol Biomarkers Prev 2008; 17: 126-34.
31. Duan L, Wu AH, Sullivan-Halley J, Bernstein L,. Passive smoking and risk of oesophageal and gastric adenocarcinomas. Br J Cancer 2009; 100: 1483-5.
32. Duan L, Wu AH, Sullivan-Halley J, Bernstein L,. Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiol Biomarkers Prev 2009; 18: 526-33.
33. Berkey CS, Hoaglin DC, Mosteller F, Colditz GA,. A random-effects regression model for meta-analysis. Stat Med 1995; 14: 395-411.
34. Thompson SG,. Systematic review: why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994; 309: 1351-5.
35. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
36. Cochran WG,. The comparison of percentages in matched samples. Biometrika 1950; 37: 256-66.
37. Centers for Disease Control and Prevention. Percentage of civilian, noninstitutionalized population with diagnosed diabetes, by age, United States, 1980-2008. Available at. Accessed on March 4, 2011.
38. Narayan KMV, Boyle JP, Thompson TJ, Gregg EW, Williamson DF,. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007; 30: 1562-6.
39. Calle EE, Kaaks R,. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-91.
40. Cronin-Fenton DP, Murray LJ, Whiteman DC, Cardwell C, Webb PM, Jordan SJ, Corley DA, Sharp L, Lagergren J,. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer 2010; 46: 2067-76.
41. Mearin F, Malagelada JR,. Gastroparesis and dyspepsia in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7: 717-23.
42. Stacher G, Lenglinger J, Bergmann H, Schneider C, Hoffmann M, Wölfl G, Stacher-Janotta G,. Gastric emptying: a contributory factor in gastro-oesophageal reflux activity? Gut 2000; 47: 661-6.
43. Boucher JL, Hurrell DG,. Cardiovascular disease and diabetes. Diabetes Spectr 2008; 21: 154-5.